Page 103 - 《中国医疗器械杂志》2026年第1期

Chinese Journal of Medical Instrumentation 2026年 第50卷 第1期

监 管 与 测 试

Dermal Fillers[EB/OL]. [2025-02-19]. https://www.fda. 12S009.
gov/medical-devices/aesthetic-cosmetic-devices/fda- [33] U. S. Food and Drug Administration. FDA executive
approved-dermal-fillers#approved. summary general issues panel meeting on dermal
[20] U. S. Food and Drug Administration. Premarket Approval fillers[EB/OL].[2025-02-19]. https://www.fda.gov/media/
(PMA)[EB/OL]. [2025-02-19]. https://www.accessdata. 146870/download.
fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P800022. [34] EU. Council Directive 93/42/EEC of 14 June 1993
[21] U. S. Food and Drug Administration. Premarket Approval concerning medical devices [EB/OL]. (1993-07-12)
(PMA)[EB/OL]. [2025-02-19]. https://www.accessdata. [2025-02-19]. https://eur-lex.europa.eu/eli/dir/1993/42/oj.
fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P800022 [35] EU. Regulation (EU) 2017/ 745 of the European
S050. Parliament and of the Council of 5 April 2017 on medical
[22] U. S. Food and Drug Administration. Premarket Approval devices[EB/OL]. (2020-04-24)[2025-02-19]. https://eur-
(PMA)[EB/OL]. [2025-02-19]. https://www.accessdata. lex.europa.eu/eli/reg/2017/745/2020-04-24.
fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P020023. [36] EU. Commission Implementing Regulation (EU)
[23] U. S. Food and Drug Administration. Premarket Approval 2022/2346 of 1 December 2022 laying down common
(PMA)[EB/OL]. [2025-02-19]. https://www.accessdata. specifications for the groups of products without an
fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P050047. intended medical purpose listed in Annex Ⅹ Ⅵ to
[24] U. S. Food and Drug Administration. Premarket Approval Regulation (EU) 2017/745 of the European Parliament
(PMA)[EB/OL]. [2025-02-19]. https://www.accessdata. and of the Council on medical devices[EB/OL]. (2022-
fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P110033. 12-02) [2025-02-19]. https://eur-lex.europa.eu/legal-content/
[25] U. S. Food and Drug Administration. Premarket Approval EN/TXT/?uri=CELEX:32022R2346.
(PMA)[EB/OL]. [2025-02-19]. https://www.accessdata. [37] EU. Commission Implementing Regulation (EU)
fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P110 2023/1194 of 20 June 2023 amending Implementing
033S070. Regulation (EU) 2022/2346 as regards the transitional
[26] U. S. Food and Drug Administration. Premarket Approval provisions for certain products without an intended
(PMA)[EB/OL]. [2025-02-19]. https://www.accessdata. medical purpose listed in Annex Ⅹ Ⅵ to Regulation (EU)
fda.gov/scripts/cdrh/devicesatfda/index.cfm?db=pma& 2017/745 of the European Parliament and of the
id=320182. Council[EB/OL]. (2023-06-21) [2025-02-19]. https://eur-
[27] U. S. Food and Drug Administration. Premarket Approval lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:
(PMA)[EB/OL]. [2025-02-19]. https://www.accessdata. 32023R1194.
fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P030 [38] EU. Regulation (EU) 2023/607 of the European
050S002. Parliament and of the Council of 15 March 2023
[28] U. S. Food and Drug Administration. Premarket Approval amending Regulations (EU) 2017/745 and (EU) 2017/746
(PMA)[EB/OL]. [2025-02-19]. https://www.accessdata. as regards the transitional provisions for certain medical
fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P03005 devices and in vitro diagnostic medical devices[EB/OL].
0S039. (2023-03-20) [2025-02-19]. https://eur-lex.europa.eu/eli/reg/
[29] U. S. Food and Drug Administration. Radiesse injectable 2023/607/oj.
implant instructions for use[EB/OL]. [2025-02-19]. https:// [39] EU. Commission Implementing Regulation (EU)
www.accessdata.fda.gov/cdrh_docs/pdf5/P050037C.pdf. 2022/2347 of 1 December 2022 laying down rules for the
[30] U. S. Food and Drug Administration. Premarket Approval application of Regulation (EU) 2017/745 of the European
(PMA)[EB/OL]. [2025-02-19]. https://www.accessdata. Parliament and of the Council as regards reclassification
fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P050052. of groups of certain active products without an intended
[31] U. S. Food and Drug Administration. Premarket Approval medical purpose[EB/OL]. (2022-12-02)[2025-02-19]. https://
(PMA)[EB/OL]. [2025-02-19]. https://www.accessdata. eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:
fda.gov/scripts/cdrh/devicesatfda/index.cfm?db=pma& 32022R2347.
id=320094. [40] EU. MDCG 2023-5 Guidance on qualification and
[32] U. S. Food and Drug Administration. Premarket Approval classification of Annex Ⅹ Ⅵ products[EB/OL]. (2023-
(PMA)[EB/OL]. [2025-02-19]. https://www.accessdata. 12)[2025-02-19]. https://health.ec.europa.eu/system/files/
fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P0200 2023-12/mdcg_2023-5_en.pdf.

99